Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)

SHE:300434 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	278.14	417.29	545.9	440.31	235.43	410.76
Short-Term Investments	-	-	101.54	-	-	-
Trading Asset Securities	29.61	14.1	42.36	63.81	53.84	73.29
Cash & Short-Term Investments	307.75	431.39	689.79	504.12	289.27	484.05
Cash Growth	-34.00%	-37.46%	36.83%	74.27%	-40.24%	16.67%
Accounts Receivable	334.56	367.37	375.99	484.87	362.27	191.83
Other Receivables	19.43	14.77	24.47	25.37	15.36	9.29
Receivables	353.99	382.14	400.46	510.24	377.63	201.11
Inventory	202.87	209.75	238.16	197.37	217.7	189.96
Prepaid Expenses	-	-	3.89	0.04	8.32	11
Other Current Assets	47.97	46.73	39.27	49.3	53.87	29.69
Total Current Assets	912.58	1,070	1,372	1,261	946.79	915.82
Property, Plant & Equipment	737.21	715.12	668.57	618.06	578.31	488.47
Long-Term Investments	426.13	350.64	102.13	120.74	134.84	82.1
Goodwill	109.25	109.25	109.25	176.76	176.76	97.12
Other Intangible Assets	200.58	205.36	225.82	244.01	262.71	248.88
Long-Term Deferred Tax Assets	15.11	14.58	14.83	9.73	10.51	6.05
Long-Term Deferred Charges	5.22	5.5	6.87	7.56	9.9	5.7
Other Long-Term Assets	576.33	584.39	602.38	621.99	648.31	650.06
Total Assets	2,982	3,055	3,101	3,060	2,768	2,494
Accounts Payable	94.73	117.08	116.55	97.3	87.64	79.66
Accrued Expenses	30.72	74.54	135.91	181.34	125.4	122.55
Short-Term Debt	50	50	110.62	10.01	-	10
Current Portion of Long-Term Debt	2.24	1.7	-	-	-	-
Current Portion of Leases	-	-	1.49	0.05	0.2	-
Current Income Taxes Payable	26.3	31.91	25.99	65.58	20.32	8.41
Current Unearned Revenue	32.33	80.93	127.14	199.89	132.32	101.64
Other Current Liabilities	121.92	135.69	83.45	123.42	154.45	30.22
Total Current Liabilities	358.24	491.84	601.17	677.58	520.34	352.49
Long-Term Debt	25	25	-	-	-	-
Long-Term Leases	0.46	1.16	2.71	0.26	0.78	-
Long-Term Unearned Revenue	4.48	4.73	4.71	3.38	3.05	3.12
Long-Term Deferred Tax Liabilities	61.24	62.13	68.52	75	81.39	79.16
Other Long-Term Liabilities	0.46	0.46	0.25	0.34	0.56	0.46
Total Liabilities	449.88	585.32	677.37	756.56	606.12	435.23
Common Stock	401.74	401.74	401.74	401.74	401.74	401.74
Additional Paid-In Capital	1,787	1,787	1,787	1,787	1,816	1,816
Retained Earnings	321.82	258.97	211.4	85.2	-133.59	-200.07
Total Common Equity	2,511	2,448	2,400	2,274	2,084	2,017
Minority Interest	21.68	21.53	23.64	29.12	78.26	41.7
Shareholders' Equity	2,533	2,470	2,424	2,303	2,162	2,059
Total Liabilities & Equity	2,982	3,055	3,101	3,060	2,768	2,494
Total Debt	77.7	77.86	114.83	10.31	0.98	10
Net Cash (Debt)	230.06	353.53	574.97	493.8	288.29	474.05
Net Cash Growth	-33.90%	-38.51%	16.44%	71.29%	-39.19%	16.51%
Net Cash Per Share	0.58	0.89	1.41	1.22	0.74	1.18
Filing Date Shares Outstanding	401.86	350.23	401.74	401.74	401.74	401.74
Total Common Shares Outstanding	401.86	350.23	401.74	401.74	401.74	401.74
Working Capital	554.34	578.18	770.42	583.48	426.45	563.33
Book Value Per Share	6.25	6.99	5.98	5.66	5.19	5.02
Tangible Book Value	2,201	2,133	2,065	1,853	1,644	1,671
Tangible Book Value Per Share	5.48	6.09	5.14	4.61	4.09	4.16
Buildings	-	-	788	584.27	601.35	572.79
Machinery	-	-	61.25	63.61	284.32	238.64
Construction In Progress	-	-	0.41	136.96	79.8	36.45

Updated Oct 23, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.